Management of post-splenectomy patients in the Netherlands

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 29, Issue 4, 2010, Pages 399-405

  Lammers, A J J ^a   Veninga, D ^a   Lombarts, M J M H ^a   Hoekstra, J B L ^a   Speelman, P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCAL VACCINE GROUP C; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ABDOMINAL ABSCESS; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DIARRHEA; FEMALE; FEVER; FOLLOW UP; HUMAN; HUMAN TISSUE; INFECTIOUS COMPLICATION; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; NETHERLANDS; NONHUMAN; PNEUMOCOCCAL INFECTION; PNEUMONIA; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; SPLENECTOMY; SURGICAL PATIENT; TREATMENT DURATION; URINARY TRACT INFECTION; VACCINATION; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; EDUCATION; FEMALE; GUIDELINE ADHERENCE; HEALTH SERVICES RESEARCH; HOSPITALS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES; SPLENECTOMY; VACCINATION; YOUNG ADULT;

EID: 77952099574     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-009-0870-x     Document Type: Article

References (23)

1. DH Morris FD Bullock 1919 The importance of the spleen in resistance to infection Ann Surg 70 513 521 10.1097/00000658-191911000-00001 1:STN:280:DC%2BD2srkvFagsw%3D%3D 17864185
2. RE Mebius G Kraal 2005 Structure and function of the spleen Nat Rev Immunol 5 606 616 10.1038/nri1669 1:CAS:528:DC%2BD2MXmvVClsb4%3D 16056254 (Pubitemid 41113192)
3. SW Hosea EJ Brown MI Hamburger, et al. 1981 Opsonic requirements for intravascular clearance after splenectomy N Engl J Med 304 245 250 1:STN:280:DyaL3M%2FnsVyqtw%3D%3D 7442756
4. JM Huston M Ochani M Rosas-Ballina, et al. 2006 Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis J Exp Med 203 1623 1628 10.1084/jem.20052362 1:CAS:528:DC%2BD28XntVCgsr8%3D 16785311 (Pubitemid 44036265)
5. M Deodhar N Kakkar 2004 An audit of splenectomies in a teaching hospital in North India. Are postsplenectomy guidelines being complied with? J Clin Pathol 57 407 410 10.1136/jcp.2003.013896 1:STN:280:DC%2BD2c7lsVOjtw%3D%3D 15047746 (Pubitemid 38446260)
6. A Newland D Provan S Myint 2005 Preventing severe infection after splenectomy BMJ 331 417 418 10.1136/bmj.331.7514.417 16110056
7. RJ Holdsworth AD Irving A Cuschieri 1991 Postsplenectomy sepsis and its mortality rate: actual versus perceived risks Br J Surg 78 1031 1038 10.1002/bjs.1800780904 1:STN:280:DyaK38%2FjtlOgug%3D%3D 1933181
8. DJ Waghorn 2001 Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed J Clin Pathol 54 214 218 10.1136/jcp.54.3.214 1:STN:280:DC%2BD3M7osFartA%3D%3D 11253134 (Pubitemid 32205043)
9. ML Brigden A Pattullo G Brown 2000 Pneumococcal vaccine administration associated with splenectomy: the need for improved education, documentation, and the use of a practical checklist Am J Hematol 65 25 29 10.1002/1096- 8652(200009)65:1<25::AID-AJH4>3.0.CO;2-8 1:STN:280:DC%2BD3cvitlOrsg%3D%3D 10936859 (Pubitemid 30659970)
10. B Styrt 1990 Infection associated with asplenia: risks, mechanisms, and prevention Am J Med 88 33N 42N 10.1016/0002-9343(90)90259-G 1:STN:280: DyaK3czhtlOrtQ%3D%3D 2114797
11. DB Singer 1973 Postsplenectomy sepsis Perspect Pediatr Pathol 1 285 311 1:STN:280:DyaE2c7ltVWntA%3D%3D 4596312
12. N Bisharat H Omari I Lavi, et al. 2001 Risk of infection and death among post-splenectomy patients J Infect 43 182 186 10.1053/jinf.2001.0904 1:STN:280:DC%2BD38%2FntFWisw%3D%3D 11798256 (Pubitemid 34211099)
13. EG Mourtzoukou G Pappas G Peppas, et al. 2008 Vaccination of asplenic or hyposplenic adults Br J Surg 95 273 280 10.1002/bjs.6106 1:STN:280: DC%2BD1c7ivVagsw%3D%3D 18278784
14. [No authors listed] 1996 Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force BMJ 312 430 434
15. JM Davies R Barnes D Milligan 2002 Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen Clin Med 2 440 443 1:STN:280:DC%2BD38nosVKisg%3D%3D 12448592
16. ME Fuentes-Ferrer S Cano-Escudero G Mato-Chaín, et al. 2008 Vaccination coverage against Streptococcus pneumoniae in splenectomized patients in a fourth-level hospital (1999-2004) Enferm Infecc Microbiol Clin 26 194 198 10.1016/S0213-005X(08)72690-9 18381038
17. B Hasse C Moll K Oehy, et al. 2005 Anti-infectious prophylaxis after splenectomy: current practice in an eastern region of Switzerland Swiss Med Wkly 135 291 296 1:STN:280:DC%2BD2MzjsFaqug%3D%3D 15986267
18. MH Kyaw EM Holmes J Chalmers, et al. 2002 A survey of vaccine coverage and antibiotic prophylaxis in splenectomised patients in Scotland J Clin Pathol 55 472 474 1:STN:280:DC%2BD38zhs1Wrtw%3D%3D 12037033
19. J O'Donnell G McGreal P Daly, et al. 2004 Management of patients undergoing splenectomy in an Irish teaching hospital: impact of guidelines Ir J Med Sci 173 136 140 10.1007/BF03167927 15693382
20. J Pickering H Campbell 2000 An audit of the vaccination and antibiotic prophylaxis practices amongst patients splenectomised in Lothian Health Bull (Edinb) 58 390 395 1:STN:280:DC%2BD3s3os1Oqtg%3D%3D
21. J Ramachandra A Bond C Ranaboldo, et al. 2003 An audit of post-splenectomy prophylaxis-are we following the guidelines? Ann R Coll Surg Engl 85 252 255 10.1308/003588403766274962 12855028 (Pubitemid 36873949)
22. DM Musher H Ceasar EM Kojic, et al. 2005 Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine J Infect Dis 191 1063 1067 10.1086/428135 1:CAS:528:DC%2BD2MXjtFyhsLc%3D 15747240 (Pubitemid 40404364)
23. H Cherif O Landgren HB Konradsen, et al. 2006 Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases Vaccine 24 75 81 10.1016/j.vaccine.2005.07.054 1:CAS:528:DC%2BD2MXht1OksrzI 16107293 (Pubitemid 41721102)